Kerry Dobbs

Kerry Dobbs

Auto-generated profile, based on publicly available information

Kerry Dobbs

Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 October 2020 in Science
Verified
Journal Article
Open access
PDF file
PBPaul Bastard
Paul Bastard
LRLindsey B. Rosen
Lindsey B. Rosen
QZQian Zhang
Qian Zhang
EMEleftherios Michailidis
Eleftherios Michailidis
HHHans-Heinrich Hoffmann
Hans-Heinrich Hoffmann
JCJean-Laurent Casanova
Jean-Laurent Casanova
The genetics underlying severe COVID-19: The immune system is complex and involves many genes, including those that encode cytokines known as interferons (IFNs). Individuals that lack specific IFNs can be more susceptible to infectious diseases. Furthermore, the autoantibody system dampens IFN response to prevent damage from pathogen-induced inflammation. Two studies now examine the likelihood that genetics affects the risk of severe coronavirus disease 2019 (COVID-19) through components of this system (see the Perspective by Beck and Aksentijevich). Q. Zhang et al. used a candidate gene approach and identified patients with severe COVID-19 who have mutations in genes involved in the regulation of type I and III IFN immunity. They found enrichment of these genes in patients and conclude that genetics may determine the clinical course of the infection. Bastard et al. identified individuals with high titers of neutralizing autoantibodies against type I IFN-α2 and IFN-ω in about 10% of patients with severe COVID-19 pneumonia. These autoantibodies were not found either in infected people who were asymptomatic or had milder phenotype or in healthy individuals. Together, these studies identify a means by which individuals at highest risk of life-threatening COVID-19 can be identified. Science , this issue p. eabd4570 , p. eabd4585 ; see also p. 404

1 April 2009 in Annual Review of Immunology
Verified
Journal Article
Closed access
MCMary Ellen Conley
Mary Ellen Conley
ADA. Kerry Dobbs
A. Kerry Dobbs
DFDana M. Farmer
Dana M. Farmer
SKSebnem Kilic
Sebnem Kilic
KPKenneth Paris
Kenneth Paris
DCDario Campana
Dario Campana
Sophisticated genetic tools have made possible the identification of the genes responsible for most well-described immunodeficiencies in the past 15 years. Mutations in Btk, components of the pre-B cell and B cell receptor (λ5, Igα, Igβ), or the scaffold protein BLNK account for approximately 90% of patients with defects in early B cell development. Hyper-IgM syndromes result from mutations in CD40 ligand, CD40, AID, or UNG in 70–80% of affected patients. Rare defects in ICOS or CD19 can result in a clinical picture that is consistent with common variable immunodeficiency, and as many as 10% of patients with this disorder have heterozygous amino acid substitutions in TACI. For all these disorders, there is considerable clinical heterogeneity in patients with the same mutation. Identifying the genetic and environmental factors that influence the clinical phenotype may enhance patient care and our understanding of normal B cell development.

11 January 2021 in JCI Insight
Verified
Journal Article
Open access
PDF file
MAMichael S. Abers
Michael S. Abers
ODOttavia M. Delmonte
Ottavia M. Delmonte
EREmily E. Ricotta
Emily E. Ricotta
JFJonathan Fintzi
Jonathan Fintzi
DFDanielle L. Fink
Danielle L. Fink
LNLuigi Daniele Notarangelo
Luigi Daniele Notarangelo
Immune and inflammatory responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) contribute to disease severity of coronavirus disease 2019 (COVID-19). However, the utility of specific immune-based biomarkers to predict clinical outcome remains elusive. Here, we analyzed levels of 66 soluble biomarkers in 175 Italian patients with COVID-19 ranging from mild/moderate to critical severity and assessed type I IFN–, type II IFN–, and NF-κB–dependent whole-blood transcriptional signatures. A broad inflammatory signature was observed, implicating activation of various immune and nonhematopoietic cell subsets. Discordance between IFN-α2a protein and IFNA2 transcript levels in blood suggests that type I IFNs during COVID-19 may be primarily produced by tissue-resident cells. Multivariable analysis of patients’ first samples revealed 12 biomarkers (CCL2, IL-15, soluble ST2 [sST2], NGAL, sTNFRSF1A, ferritin, IL-6, S100A9, MMP-9, IL-2, sVEGFR1, IL-10) that when increased were independently associated with mortality. Multivariate analyses of longitudinal biomarker trajectories identified 8 of the aforementioned biomarkers (IL-15, IL-2, NGAL, CCL2, MMP-9, sTNFRSF1A, sST2, IL-10) and 2 additional biomarkers (lactoferrin, CXCL9) that were substantially associated with mortality when increased, while IL-1α was associated with mortality when decreased. Among these, sST2, sTNFRSF1A, IL-10, and IL-15 were consistently higher throughout the hospitalization in patients who died versus those who recovered, suggesting that these biomarkers may provide an early warning of eventual disease outcome.

25 May 2015 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
BBBertrand Boisson
Bertrand Boisson
ELEmmanuel Laplantine
Emmanuel Laplantine
KDKerry Dobbs
Kerry Dobbs
ACAurélie Cobat
Aurélie Cobat
NTNadine Tarantino
Nadine Tarantino
LNLuigi Daniele Notarangelo
Luigi Daniele Notarangelo
Inherited, complete deficiency of human HOIL-1, a component of the linear ubiquitination chain assembly complex (LUBAC), underlies autoinflammation, infections, and amylopectinosis. We report the clinical description and molecular analysis of a novel inherited disorder of the human LUBAC complex. A patient with multiorgan autoinflammation, combined immunodeficiency, subclinical amylopectinosis, and systemic lymphangiectasia, is homozygous for a mutation in HOIP, the gene encoding the catalytic component of LUBAC. The missense allele (L72P, in the PUB domain) is at least severely hypomorphic, as it impairs HOIP expression and destabilizes the whole LUBAC complex. Linear ubiquitination and NF-κB activation are impaired in the patient’s fibroblasts stimulated by IL-1β or TNF. In contrast, the patient’s monocytes respond to IL-1β more vigorously than control monocytes. However, the activation and differentiation of the patient’s B cells are impaired in response to CD40 engagement. These cellular and clinical phenotypes largely overlap those of HOIL-1-deficient patients. Clinical differences between HOIL-1- and HOIP-mutated patients may result from differences between the mutations, the loci, or other factors. Our findings show that human HOIP is essential for the assembly and function of LUBAC and for various processes governing inflammation and immunity in both hematopoietic and nonhematopoietic cells.

1 April 2021 in Cell
Verified
Journal Article
Closed access
CLCan Liu
Can Liu
AMAndrew J. Martins
Andrew J. Martins
WLWilliam W. Lau
William W. Lau
NRNicholas Rachmaninoff
Nicholas Rachmaninoff
JCJinguo Chen
Jinguo Chen
JTJohn S. Tsang
John S. Tsang

17 February 2022 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
KSKeith Sacco
Keith Sacco
Riccardo CastagnoliRiccardo Castagnoli
Riccardo Castagnoli
SVSvetlana Vakkilainen
Svetlana Vakkilainen
CLCan Liu
Can Liu
ODOttavia M. Delmonte
Ottavia M. Delmonte
LMLorenza Montagna
Lorenza Montagna